

Point of Care (POC) Diagnostic Devices Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Point of Care (POC) Diagnostic Devices market is expected to witness significant growth due to increasing demand for rapid and accurate diagnostic tools. The market size is projected to reach USD 40.8 billion by 2027 with a CAGR of 8.7% during the forecast period. Key drivers include advancements in technology and rising prevalence of infectious diseases.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Roche Diagnostics
◍ Abaxis
◍ Abbott POC
◍ Abbott
◍ Beckman Coulter
◍ Beckton and Dickinson
◍ Bayer Diabetes Care
◍ Hemocue AB
◍ International Technidyne Corporation
◍ LifeScan Inc
◍ Nipro Diagnostics
◍ Orasure Technologies
◍ PointCare Technologies
◍ Siemens HealthCare Diagnostics
The Point of Care (POC) Diagnostic Devices Market includes key players such as Roche Diagnostics, Abaxis, Abbott POC, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, and Siemens HealthCare Diagnostics. These companies offer a range of diagnostic devices for rapid testing outside of traditional laboratory settings, contributing to the growth of the POC diagnostic devices market.
- Roche Diagnostics sales revenue $14.8 billion
- Abbott sales revenue $30.6 billion
- Siemens HealthCare Diagnostics sales revenue $13.1 billion
◍ Patient Self-Testing
◍ Clinics
◍ Hospitals
◍ Laboratories
◍ Others
◍ Miniaturization and Microfluidics Technology
◍ Molecular Diagnostics
◍ Non-Invasive Technology
◍ Others
Request Sample Report